Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4996
Abstract: In this open‐label, Phase 1 study, we explore the safety and efficacy of E7389‐LF (liposomal formulation of eribulin) in Japanese patients with advanced solid tumors.
read more here.
Keywords:
adenoid cystic;
cystic carcinoma;
advanced adenoid;
liposomal eribulin ... See more keywords